Medeon Biodesign, Inc. (TPEX:6499)
93.30
-3.90 (-4.01%)
At close: Mar 27, 2026
Medeon Biodesign Revenue
In the year 2025, Medeon Biodesign had annual revenue of 419.43M TWD with 43.24% growth. Medeon Biodesign had revenue of 114.87M in the quarter ending December 31, 2025, with 48.51% growth.
Revenue
419.43M
Revenue Growth
+43.24%
P/S Ratio
21.57
Revenue / Employee
10.75M
Employees
39
Market Cap
9.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 419.43M | 126.62M | 43.24% |
| Dec 31, 2024 | 292.81M | 96.55M | 49.19% |
| Dec 31, 2023 | 196.26M | -102.05M | -34.21% |
| Dec 31, 2022 | 298.32M | 229.36M | 332.61% |
| Dec 31, 2021 | 68.96M | -54.10M | -43.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pegavision | 7.04B |
| Visco Vision | 4.22B |
| Formosa Optical Technology | 4.13B |
| St.Shine Optical | 4.12B |
| Vizionfocus | 3.49B |
| Pacific Hospital Supply | 2.41B |
| Nang Kuang Pharmaceutical | 2.16B |
| Bioteque | 2.14B |